Shulamit Michaeli
What You Need to Know About Cell Transfection Nanoparticles can be manufactured with tunable size, shape, and surface as well as biological activity. Their role as nanocarriers is well established. While many nanoparticles are stable as an aqueous colloid, ferrofluid, they maintain an insufficient active surface and are limited in their capacity for further modification…
Read More
Leishmaniasis is a vector-borne tropical disease that affects 88 countries worldwide. The causal agent is a parasitic protozoon, Leishmania ssp. Cutaneous leishmaniasis (CL), caused by L. major, L. mexicana, and visceral leishmaniasis caused by L. donovani, is one of the most important neglected tropical diseases. Available treatments are highly toxic, and the serious side effects…
Read More
Nanodrug tames leishmaniasis and other parasitic diseases Bar-Ilan researcher working to commercialize her formula that protects against and treats diseases from trypanosomes transmitted by biting flies. Prof. Shulamit Michaeli, vice president for research at Israel’s Bar-Ilan University, is working to commercialize a nanodrug to protect against and treat leishmaniasis and other diseases caused by trypanosomes…
Read More
Bar-Ilan University: a habitat for interdisciplinary science Professor Shulamit Michaeli presents Bar-Ilan University, a Tel Aviv-based university boasting big ambitions, unparalleled achievements, and ever-increasing academic prowess. from: Health Europa: 16th July 2018 to the article
Read More
הסוד למורכבות גנטית אצל בני האדם פרופ’ שולמית מיכאלי, סגנית נשיא למחקר באוניברסיטת בר-אילן, חוקרת את המנגנון הגנטי שמסביר מדוע אנו הרבה יותר מורכבים מכפי שחשבו עד שנות ה-2000, ואיך מיישמים את הידע שנצבר על האינטראקציה בין גנים בטיפול בשושנת יריחו. לאדם ולגרגר אורז יש מספר גנים די דומה – כ-30-45 אלף גנים בעלי תפקיד…
Read More
Recent Comments